Pfizer, Pharmaceutical giant, has said early efficacy tests of its coronavirus vaccine shows that it’s 90 percent effective.
The news announced Monday November 9, by Pfizer and its German partner, BioNTech SE, comes as a welcome development to mankind as the disease has killed 1.26 million people worpdwide and almost 240,000 people in the U.S. alone.
In a statement released, Albert Bourla, Pfizer’s chairman and chief executive said;
“The results demonstrate that our mRNA-based vaccine can help prevent COVID-19 in the majority of people who receive it.”
“This means we are one step closer to potentially providing people around the world with a much-needed breakthrough to help bring an end to this global pandemic.”
“This is a first but critical step as we continue our work to deliver a safe and effective vaccine,” he added.
Bourla went on to say that more data is needed before the company can apply for FDA Emergency Use Authorization, and clinical studies are still ongoing.
“We look forward to sharing additional updates in the coming weeks and will continue to work closely with regulatory authorities to provide access to our anticipated vaccine for those who need it most,” added Bourla, who thanked the “thousands of people who volunteered to participate in the clinical trial” and the health experts working on “this crucial endeavor.”